HUE056419T2 - Vilanterol trifenatát amorf formája, és eljárások ennek elkészítésére - Google Patents
Vilanterol trifenatát amorf formája, és eljárások ennek elkészítéséreInfo
- Publication number
- HUE056419T2 HUE056419T2 HUE18752193A HUE18752193A HUE056419T2 HU E056419 T2 HUE056419 T2 HU E056419T2 HU E18752193 A HUE18752193 A HU E18752193A HU E18752193 A HUE18752193 A HU E18752193A HU E056419 T2 HUE056419 T2 HU E056419T2
- Authority
- HU
- Hungary
- Prior art keywords
- preparation
- methods
- amorphous form
- vilanterol triphenate
- triphenate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
- C07C217/08—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to an acyclic carbon atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/10—Separation; Purification; Stabilisation; Use of additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/56—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups
- C07C215/58—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups with hydroxy groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain
- C07C215/60—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups with hydroxy groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain the chain having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Inorganic Compounds Of Heavy Metals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PT2017110209 | 2017-07-19 | ||
| PT110209A PT110209B (pt) | 2017-07-19 | 2017-07-19 | Formas polimórficas de trifenatato de vilanterol e processos para a preparação das mesmas. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE056419T2 true HUE056419T2 (hu) | 2022-02-28 |
Family
ID=63143265
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE18752193A HUE056419T2 (hu) | 2017-07-19 | 2018-07-09 | Vilanterol trifenatát amorf formája, és eljárások ennek elkészítésére |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US11434194B2 (he) |
| EP (2) | EP3655386A2 (he) |
| JP (2) | JP2020528057A (he) |
| KR (2) | KR102572035B1 (he) |
| CN (3) | CN115819257A (he) |
| AU (2) | AU2018303782B9 (he) |
| BR (1) | BR112020001171A2 (he) |
| CA (2) | CA3069869A1 (he) |
| DK (1) | DK3652148T3 (he) |
| ES (1) | ES2899367T3 (he) |
| HU (1) | HUE056419T2 (he) |
| IL (3) | IL272109B2 (he) |
| MX (2) | MX392899B (he) |
| PL (1) | PL3652148T3 (he) |
| PT (1) | PT110209B (he) |
| WO (2) | WO2019016511A2 (he) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT110209B (pt) | 2017-07-19 | 2021-05-17 | Hovione Farm Sa | Formas polimórficas de trifenatato de vilanterol e processos para a preparação das mesmas. |
| EP4013398B1 (en) * | 2019-08-16 | 2025-12-31 | Melody Healthcare Pvt. Ltd. | IMPROVED PROCESS FOR THE PREPARATION OF VILANTEROL OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF |
| ES2995090T3 (en) * | 2020-07-27 | 2025-02-05 | Inke Sa | Method for the purification of vilanterol trifenatate |
| CN114441677B (zh) * | 2022-01-25 | 2024-06-11 | 上海方予健康医药科技有限公司 | 一种同时检测三苯乙酸维兰特罗多种基因杂质的方法 |
| CN116199590B (zh) * | 2022-12-26 | 2024-12-24 | 湖北美林药业有限公司 | 一种盐酸多巴酚丁胺及其注射剂 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20090057477A (ko) | 2001-09-14 | 2009-06-05 | 글락소 그룹 리미티드 | 호흡기 질환 치료용 펜에탄올아민 유도체 |
| US20150239862A1 (en) * | 2012-09-13 | 2015-08-27 | Perrigo Api Ltd. | Process for the preparation of vilanterol and intermediates thereof |
| EP3148521B1 (en) | 2014-05-28 | 2019-12-18 | GlaxoSmithKline Intellectual Property Development Limited | Fluticasone furoate in the treatment of copd |
| WO2017001907A1 (en) * | 2015-06-29 | 2017-01-05 | Teva Pharmaceuticals International Gmbh | Biocatalytic processes for the preparation of vilanterol |
| PT110209B (pt) | 2017-07-19 | 2021-05-17 | Hovione Farm Sa | Formas polimórficas de trifenatato de vilanterol e processos para a preparação das mesmas. |
-
2017
- 2017-07-19 PT PT110209A patent/PT110209B/pt active IP Right Grant
-
2018
- 2018-07-09 AU AU2018303782A patent/AU2018303782B9/en not_active Ceased
- 2018-07-09 CA CA3069869A patent/CA3069869A1/en active Pending
- 2018-07-09 PL PL18752193T patent/PL3652148T3/pl unknown
- 2018-07-09 CN CN202211471062.1A patent/CN115819257A/zh active Pending
- 2018-07-09 DK DK18752193.5T patent/DK3652148T3/da active
- 2018-07-09 ES ES18752193T patent/ES2899367T3/es active Active
- 2018-07-09 WO PCT/GB2018/051939 patent/WO2019016511A2/en not_active Ceased
- 2018-07-09 CA CA3070043A patent/CA3070043A1/en active Pending
- 2018-07-09 CN CN201880060197.4A patent/CN111094235A/zh active Pending
- 2018-07-09 MX MX2020000548A patent/MX392899B/es unknown
- 2018-07-09 IL IL272109A patent/IL272109B2/he unknown
- 2018-07-09 CN CN201880060726.0A patent/CN111108091B/zh not_active Expired - Fee Related
- 2018-07-09 KR KR1020207004628A patent/KR102572035B1/ko active Active
- 2018-07-09 US US16/631,683 patent/US11434194B2/en active Active
- 2018-07-09 EP EP18752192.7A patent/EP3655386A2/en not_active Withdrawn
- 2018-07-09 IL IL298421A patent/IL298421A/he unknown
- 2018-07-09 US US16/631,685 patent/US11414374B2/en active Active
- 2018-07-09 HU HUE18752193A patent/HUE056419T2/hu unknown
- 2018-07-09 EP EP18752193.5A patent/EP3652148B1/en active Active
- 2018-07-09 KR KR1020207004626A patent/KR20200030106A/ko active Pending
- 2018-07-09 WO PCT/GB2018/051940 patent/WO2019016512A1/en not_active Ceased
- 2018-07-09 BR BR112020001171-1A patent/BR112020001171A2/pt not_active IP Right Cessation
- 2018-07-09 JP JP2020502459A patent/JP2020528057A/ja active Pending
- 2018-07-09 AU AU2018303293A patent/AU2018303293B2/en not_active Ceased
-
2020
- 2020-01-15 MX MX2022013014A patent/MX2022013014A/es unknown
- 2020-01-17 IL IL272108A patent/IL272108A/he unknown
-
2023
- 2023-05-08 JP JP2023076831A patent/JP2023103328A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUE054103T2 (hu) | Izokinolin-3-il-karboxamidok, ezek elõállítása és alkalmazása | |
| HUE046756T2 (hu) | Benzoxazepin-oxazolidinon vegyületek és azok alkalmazási módszerei | |
| HUE048284T2 (hu) | Anti-CD40 antitestek és alkalmazásuk | |
| HUE059788T2 (hu) | PD-1 elleni antitestek és készítmények | |
| HUE060165T2 (hu) | PD-1 elleni ellenanyagok és alkalmazásukra szolgáló eljárások | |
| HUE055221T2 (hu) | Tetrahidropiranil amino-pirrolopirimidinon és eljárások annak felhasználására | |
| HUE047784T2 (hu) | Anti-TIM3 antitestek és alkalmazási eljárások | |
| HUE046000T2 (hu) | Antiproferatív vegyületek és alkalmazásuk módszerei | |
| HUE045216T2 (hu) | Anti-CD79B antitestek és alkalmazási eljárások | |
| HUE043310T2 (hu) | COT modulátorok és eljárások alkalmazásukra | |
| HUE055755T2 (hu) | Szulfonolkarmabidok és rokon vegyületeik valamint felhasználásuk | |
| HUE057607T2 (hu) | Pirazol-pirimidin-származék és annak felhasználása | |
| HUE053908T2 (hu) | Amid-szubsztituált piridiniltriazol-származékok és alkalmazásuk | |
| HUE039899T2 (hu) | Bardoxolon-metil 2,2-difluorpropionamid-származékai, ennek polimorf formái és eljárások ezek alkalmazására | |
| HUE052095T2 (hu) | Keratin kezelési készítmények és eljárások | |
| HUE052771T2 (hu) | C10orf54 elleni antitestek és alkalmazásuk | |
| HUE052373T2 (hu) | Szubsztituált krománok és alkalmazási eljárások | |
| HUE042616T2 (hu) | Eljárás és forgógépes reaktor | |
| HUE040395T2 (hu) | Ápolóeszköz és eljárás | |
| HUE053541T2 (hu) | Eljárások és készítmények brachitikus kukoricanövények elõállítására | |
| HUE055805T2 (hu) | Aceszulfám-kálium kompozíciók és eljárások ezek elõállítására | |
| HUE054874T2 (hu) | Magas elaszticitású hialuronán készítmények és alkalmazási eljárások | |
| HUE046509T2 (hu) | Új vegyület és eljárás | |
| HUE058877T2 (hu) | (R)-2-hidroxi-2-metil-4-(2,4,5-trimetil-3,6-dioxociklohexa-1,4-dienil)butánamid polimorf és amorf alakjai | |
| HUE054093T2 (hu) | Anti-HtrA1 antitestek és azok alkalmazási eljárásai |